(-)-demecolcine decreases expression ISO RGD:1313374 6480464 Demecolcine results in decreased expression of RBL1 mRNA CTD PMID:23649840 (S)-nicotine multiple interactions ISO RGD:1313374 6480464 Nicotine inhibits the reaction [RBL1 protein binds to CDC25A promoter], Nicotine inhibits the reaction [RBL1 protein binds to CDC6 promoter] CTD PMID:16862215 1,1-dichloroethene increases expression ISO RGD:1313375 6480464 vinylidene chloride results in increased expression of RBL1 mRNA CTD PMID:26682919 1,2-dimethylhydrazine decreases expression ISO RGD:1313375 6480464 1, 2-Dimethylhydrazine results in decreased expression of RBL1 mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions ISO RGD:1313375 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of RBL1 mRNA CTD PMID:22206623 17beta-estradiol multiple interactions ISO RGD:1313374 6480464 EGF protein inhibits the reaction [Estradiol results in increased expression of RBL1 mRNA] CTD PMID:24758408 17beta-estradiol increases expression ISO RGD:1313374 6480464 Estradiol results in increased expression of RBL1 mRNA CTD PMID:24758408 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:1313375 6480464 [2 more ... CTD PMID:25510870 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO RGD:1313375 6480464 [2 more ... CTD PMID:25510870 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1313374 6480464 Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of RBL1 mRNA] CTD PMID:11007951 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of RBL1 mRNA CTD PMID:32109520 , PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1313374 6480464 Tetrachlorodibenzodioxin results in decreased expression of RBL1 mRNA CTD PMID:23152189 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1313375 6480464 Tetrachlorodibenzodioxin affects the expression of RBL1 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1313375 6480464 Tetrachlorodibenzodioxin results in increased expression of RBL1 mRNA CTD PMID:15667827 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1313374 6480464 Tetrachlorodibenzodioxin results in increased expression of RBL1 mRNA CTD PMID:11007951 4-(ethoxymethylene)-2-phenyloxazol-5-one increases expression ISO RGD:1313375 6480464 Oxazolone results in increased expression of RBL1 mRNA CTD PMID:11379042 4-hydroxynon-2-enal increases expression ISO RGD:1313375 6480464 4-hydroxy-2-nonenal results in increased expression of RBL1 mRNA CTD PMID:19191707 4-nitrophenol decreases expression ISO RGD:1313375 6480464 4-nitrophenol results in decreased expression of RBL1 mRNA CTD PMID:34673133 5-aza-2'-deoxycytidine decreases expression ISO RGD:1313375 6480464 Decitabine results in decreased expression of RBL1 mRNA CTD PMID:27915011 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of RBL1 mRNA CTD PMID:24780913 acetamide increases expression EXP 6480464 acetamide results in increased expression of RBL1 mRNA CTD PMID:31881176 aflatoxin B1 decreases expression ISO RGD:1313375 6480464 Aflatoxin B1 results in decreased expression of RBL1 mRNA CTD PMID:19770486 all-trans-retinoic acid increases expression ISO RGD:1313375 6480464 Tretinoin results in increased expression of RBL1 protein CTD PMID:15231690 all-trans-retinoic acid decreases expression ISO RGD:1313374 6480464 Tretinoin results in decreased expression of RBL1 mRNA CTD PMID:33167477 alvocidib decreases expression ISO RGD:1313374 6480464 alvocidib results in decreased expression of RBL1 protein CTD PMID:9829756 amphetamine decreases expression EXP 6480464 Amphetamine results in decreased expression of RBL1 mRNA CTD PMID:30779732 antimycin A decreases expression ISO RGD:1313375 6480464 Antimycin A results in decreased expression of RBL1 mRNA CTD PMID:19304788 antirheumatic drug increases expression ISO RGD:1313374 6480464 Antirheumatic Agents results in increased expression of RBL1 mRNA CTD PMID:24449571 aristolochic acid A decreases expression ISO RGD:1313374 6480464 aristolochic acid I results in decreased expression of RBL1 mRNA CTD PMID:33212167 arsenous acid decreases methylation ISO RGD:1313374 6480464 Arsenic Trioxide results in decreased methylation of RBL1 promoter CTD PMID:29159499 atrazine multiple interactions ISO RGD:1313374 6480464 [Atrazine co-treated with Arsenates] results in increased expression of RBL1 mRNA CTD PMID:18585445 benzo[a]pyrene decreases expression ISO RGD:1313375 6480464 Benzo(a)pyrene results in decreased expression of RBL1 mRNA CTD PMID:19770486 benzo[a]pyrene increases expression ISO RGD:1313374 6480464 Benzo(a)pyrene results in increased expression of RBL1 mRNA CTD PMID:32234424 , PMID:33411230 benzo[a]pyrene increases methylation ISO RGD:1313374 6480464 Benzo(a)pyrene results in increased methylation of RBL1 promoter CTD PMID:27901495 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1313374 6480464 7 more ... CTD PMID:20382639 bis(2-chloroethyl) sulfide increases expression ISO RGD:1313375 6480464 Mustard Gas results in increased expression of RBL1 mRNA CTD PMID:15674843 bis(2-chloroethyl) sulfide decreases expression ISO RGD:1313374 6480464 Mustard Gas results in decreased expression of RBL1 mRNA CTD PMID:33491125 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of RBL1 mRNA CTD PMID:25181051 bisphenol A increases expression ISO RGD:1313374 6480464 bisphenol A results in increased expression of RBL1 protein CTD PMID:32981897 bisphenol A decreases expression ISO RGD:1313374 6480464 bisphenol A results in decreased expression of RBL1 mRNA CTD PMID:29275510 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Genistein] results in increased methylation of RBL1 gene CTD PMID:28505145 butanal decreases expression ISO RGD:1313374 6480464 butyraldehyde results in decreased expression of RBL1 mRNA CTD PMID:26079696 caffeine affects phosphorylation ISO RGD:1313374 6480464 Caffeine affects the phosphorylation of RBL1 protein CTD PMID:35688186 calcitriol decreases expression ISO RGD:1313374 6480464 Calcitriol results in decreased expression of RBL1 mRNA CTD PMID:21592394 calcitriol multiple interactions ISO RGD:1313374 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of RBL1 mRNA CTD PMID:21592394 calyculin a multiple interactions ISO RGD:1313374 6480464 calyculin A inhibits the reaction [Hydrogen Peroxide results in decreased phosphorylation of RBL1 protein] CTD PMID:12621062 camptothecin decreases expression ISO RGD:1313374 6480464 Camptothecin results in decreased expression of RBL1 protein CTD PMID:15585644 carbon nanotube increases expression ISO RGD:1313375 6480464 Nanotubes more ... CTD PMID:25554681 CGP 52608 multiple interactions ISO RGD:1313374 6480464 CGP 52608 promotes the reaction [RORA protein binds to RBL1 gene] CTD PMID:28238834 chloroprene decreases expression ISO RGD:1313375 6480464 Chloroprene results in decreased expression of RBL1 mRNA CTD PMID:23125180 chlorpyrifos decreases expression ISO RGD:1313375 6480464 Chlorpyrifos results in decreased expression of RBL1 mRNA CTD PMID:20350560 cobalt dichloride decreases expression ISO RGD:1313374 6480464 cobaltous chloride results in decreased expression of RBL1 mRNA CTD PMID:19320972 , PMID:19376846 copper atom multiple interactions ISO RGD:1313374 6480464 [Chelating Agents binds to Copper] which results in increased expression of RBL1 mRNA, [NSC 689534 binds to Copper] which results in decreased expression of RBL1 mRNA CTD PMID:20971185 , PMID:30911355 copper(0) multiple interactions ISO RGD:1313374 6480464 [Chelating Agents binds to Copper] which results in increased expression of RBL1 mRNA, [NSC 689534 binds to Copper] which results in decreased expression of RBL1 mRNA CTD PMID:20971185 , PMID:30911355 copper(II) sulfate decreases expression ISO RGD:1313374 6480464 Copper Sulfate results in decreased expression of RBL1 mRNA CTD PMID:19549813 cycloheximide multiple interactions ISO RGD:1313374 6480464 Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of RBL1 mRNA] more ... CTD PMID:11007951 , PMID:20100483 cycloheximide decreases expression ISO RGD:1313374 6480464 Cycloheximide results in decreased expression of RBL1 protein CTD PMID:20100483 D-mannitol decreases expression ISO RGD:1313375 6480464 Mannitol results in decreased expression of RBL1 mRNA CTD PMID:25270620 diarsenic trioxide decreases methylation ISO RGD:1313374 6480464 Arsenic Trioxide results in decreased methylation of RBL1 promoter CTD PMID:29159499 dibutyl phthalate decreases expression ISO RGD:1313375 6480464 Dibutyl Phthalate results in decreased expression of RBL1 mRNA CTD PMID:17361019 , PMID:21266533 doxorubicin decreases expression ISO RGD:1313374 6480464 Doxorubicin results in decreased expression of RBL1 protein CTD PMID:16537896 folic acid multiple interactions ISO RGD:1313375 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of RBL1 mRNA CTD PMID:22206623 folic acid increases expression ISO RGD:1313374 6480464 Folic Acid results in increased expression of RBL1 mRNA CTD PMID:21867686 folic acid decreases expression ISO RGD:1313375 6480464 Folic Acid results in decreased expression of RBL1 mRNA CTD PMID:25629700 furan increases expression EXP 6480464 furan results in increased expression of RBL1 mRNA CTD PMID:22079235 genistein multiple interactions EXP 6480464 [bisphenol A co-treated with Genistein] results in increased methylation of RBL1 gene CTD PMID:28505145 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of RBL1 mRNA CTD PMID:33387578 glyphosate decreases expression ISO RGD:1313374 6480464 glyphosate results in decreased expression of RBL1 mRNA CTD PMID:31295307 GW 3965 decreases expression ISO RGD:1313374 6480464 GW 3965 results in decreased expression of RBL1 mRNA CTD PMID:31437187 hydralazine multiple interactions ISO RGD:1313374 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of RBL1 mRNA CTD PMID:17183730 hydrogen peroxide multiple interactions ISO RGD:1313374 6480464 calyculin A inhibits the reaction [Hydrogen Peroxide results in decreased phosphorylation of RBL1 protein], Okadaic Acid inhibits the reaction [Hydrogen Peroxide results in decreased phosphorylation of RBL1 protein] CTD PMID:12621062 hydrogen peroxide decreases phosphorylation ISO RGD:1313374 6480464 Hydrogen Peroxide results in decreased phosphorylation of RBL1 protein CTD PMID:12621062 irinotecan decreases expression ISO RGD:1313374 6480464 Irinotecan metabolite results in decreased expression of RBL1 mRNA, Irinotecan results in decreased expression of RBL1 mRNA CTD PMID:15956246 lamivudine multiple interactions ISO RGD:1313374 6480464 [Zidovudine co-treated with Lamivudine] results in decreased expression of RBL1 mRNA CTD PMID:15784690 Lasiocarpine multiple interactions ISO RGD:1313374 6480464 [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of RBL1 mRNA CTD PMID:33884520 lidocaine affects expression ISO RGD:1313375 6480464 Lidocaine affects the expression of RBL1 mRNA CTD PMID:18931217 lidocaine increases expression EXP 6480464 Lidocaine results in increased expression of RBL1 mRNA CTD PMID:35283115 lipopolysaccharide increases expression ISO RGD:1313375 6480464 Lipopolysaccharides results in increased expression of RBL1 mRNA CTD PMID:10975854 LY294002 decreases expression ISO RGD:1313375 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of RBL1 protein CTD PMID:15601625 methotrexate increases expression ISO RGD:1313374 6480464 Methotrexate results in increased expression of RBL1 mRNA CTD PMID:24449571 methoxyacetic acid multiple interactions EXP 6480464 methoxyacetic acid results in decreased phosphorylation of and results in decreased expression of RBL1 protein CTD PMID:11313878 methylmercury chloride decreases expression ISO RGD:1313374 6480464 methylmercuric chloride results in decreased expression of RBL1 mRNA CTD PMID:28001369 monocrotaline multiple interactions ISO RGD:1313374 6480464 [CYP3A4 protein results in increased metabolism of Monocrotaline] which results in decreased expression of RBL1 mRNA CTD PMID:33884520 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal increases expression ISO RGD:1313374 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of RBL1 protein CTD PMID:20100483 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal increases ubiquitination ISO RGD:1313374 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased ubiquitination of RBL1 protein CTD PMID:20100483 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO RGD:1313374 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [palbociclib results in decreased expression of RBL1 protein], palbociclib promotes the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased ubiquitination of RBL1 protein] CTD PMID:20100483 N-nitrosodiethylamine multiple interactions ISO RGD:1313375 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of RBL1 mRNA more ... CTD PMID:17854601 more ... N-nitrosodiethylamine increases expression ISO RGD:1313375 6480464 Diethylnitrosamine results in increased expression of RBL1 mRNA, Diethylnitrosamine results in increased expression of RBL1 protein CTD PMID:17854601 , PMID:19887370 nicotine multiple interactions ISO RGD:1313374 6480464 Nicotine inhibits the reaction [RBL1 protein binds to CDC25A promoter], Nicotine inhibits the reaction [RBL1 protein binds to CDC6 promoter] CTD PMID:16862215 okadaic acid multiple interactions ISO RGD:1313374 6480464 Okadaic Acid inhibits the reaction [Hydrogen Peroxide results in decreased phosphorylation of RBL1 protein] CTD PMID:12621062 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of RBL1 mRNA CTD PMID:25729387 oxaliplatin decreases expression EXP 6480464 oxaliplatin results in decreased expression of RBL1 mRNA CTD PMID:25729387 ozone multiple interactions ISO RGD:1313375 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of RBL1 mRNA, [Air Pollutants results in increased abundance of Ozone] which results in increased expression of RBL1 mRNA CTD PMID:34911549 palbociclib multiple interactions ISO RGD:1313374 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [palbociclib results in decreased expression of RBL1 protein] more ... CTD PMID:20100483 palbociclib decreases expression ISO RGD:1313374 6480464 palbociclib results in decreased expression of RBL1 mRNA, palbociclib results in decreased expression of RBL1 protein CTD PMID:20100483 , PMID:20473330 paracetamol increases expression ISO RGD:1313374 6480464 Acetaminophen results in increased expression of RBL1 mRNA CTD PMID:22230336 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of RBL1 mRNA CTD PMID:33387578 PCB138 multiple interactions ISO RGD:1313375 6480464 [2 more ... CTD PMID:25510870 phenobarbital increases expression ISO RGD:1313375 6480464 Phenobarbital results in increased expression of RBL1 mRNA CTD PMID:19482888 phenobarbital affects expression ISO RGD:1313375 6480464 Phenobarbital affects the expression of RBL1 mRNA CTD PMID:23091169 phenobarbital multiple interactions ISO RGD:1313375 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of RBL1 mRNA, NR1I3 protein affects the reaction [Phenobarbital results in increased expression of RBL1 mRNA] CTD PMID:19482888 , PMID:24535843 pirinixic acid multiple interactions ISO RGD:1313375 6480464 [pirinixic acid co-treated with PPARA] results in increased expression of RBL1 mRNA, PPARA protein promotes the reaction [pirinixic acid results in increased expression of RBL1 mRNA] CTD PMID:17950772 , PMID:20813756 pirinixic acid increases expression ISO RGD:1313375 6480464 pirinixic acid results in increased expression of RBL1 mRNA CTD PMID:17950772 , PMID:20813756 pregnenolone 16alpha-carbonitrile multiple interactions ISO RGD:1313375 6480464 [1 more ... CTD PMID:23626729 quercetin decreases expression ISO RGD:1313374 6480464 Quercetin results in decreased expression of RBL1 mRNA CTD PMID:23727915 quercetin increases expression ISO RGD:1313375 6480464 Quercetin results in increased expression of RBL1 mRNA CTD PMID:25862958 riddelliine multiple interactions ISO RGD:1313374 6480464 [CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of RBL1 mRNA CTD PMID:33884520 ritonavir increases expression ISO RGD:1313374 6480464 Ritonavir results in increased expression of RBL1 mRNA CTD PMID:19386116 rotenone decreases expression ISO RGD:1313375 6480464 Rotenone results in decreased expression of RBL1 mRNA CTD PMID:19304788 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of RBL1 mRNA CTD PMID:28374803 silicon dioxide increases expression ISO RGD:1313374 6480464 Silicon Dioxide analog results in increased expression of RBL1 mRNA CTD PMID:25895662 silver(1+) nitrate increases expression ISO RGD:1313374 6480464 Silver Nitrate analog results in increased expression of RBL1 mRNA, Silver Nitrate results in increased expression of RBL1 mRNA CTD PMID:22831968 sirolimus multiple interactions ISO RGD:1313374 6480464 [TGFB1 protein co-treated with Sirolimus] inhibits the reaction [[E2F4 protein binds to RBL1 protein] which binds to CDK2 protein] CTD PMID:12417722 sodium arsenite increases expression ISO RGD:1313375 6480464 sodium arsenite results in increased expression of RBL1 mRNA CTD PMID:16014739 succimer multiple interactions ISO RGD:1313375 6480464 [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RBL1 mRNA CTD PMID:21641980 sunitinib decreases expression ISO RGD:1313374 6480464 Sunitinib results in decreased expression of RBL1 mRNA CTD PMID:31533062 tamoxifen increases phosphorylation ISO RGD:1313375 6480464 Tamoxifen results in increased phosphorylation of RBL1 protein CTD PMID:15642790 testosterone decreases expression ISO RGD:1313374 6480464 Testosterone results in decreased expression of RBL1 mRNA CTD PMID:21592394 testosterone multiple interactions ISO RGD:1313374 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of RBL1 mRNA CTD PMID:21592394 tetrachloromethane increases expression ISO RGD:1313375 6480464 Carbon Tetrachloride results in increased expression of RBL1 mRNA, Carbon Tetrachloride results in increased expression of RBL1 protein CTD PMID:19887370 , PMID:31919559 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of RBL1 mRNA CTD PMID:23411599 , PMID:34492290 toluene 2,4-diisocyanate increases expression ISO RGD:1313375 6480464 Toluene 2, 4-Diisocyanate results in increased expression of RBL1 mRNA CTD PMID:11379042 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of RBL1 mRNA CTD PMID:25729387 troglitazone decreases expression ISO RGD:1313374 6480464 troglitazone results in decreased expression of RBL1 mRNA CTD PMID:19140230 trovafloxacin decreases expression ISO RGD:1313375 6480464 trovafloxacin results in decreased expression of RBL1 mRNA CTD PMID:35537566 valproic acid affects expression ISO RGD:1313375 6480464 Valproic Acid affects the expression of RBL1 mRNA CTD PMID:17963808 valproic acid decreases expression ISO RGD:1313374 6480464 Valproic Acid results in decreased expression of RBL1 mRNA CTD PMID:28001369 valproic acid multiple interactions ISO RGD:1313374 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of RBL1 mRNA CTD PMID:17183730 vincristine decreases expression ISO RGD:1313374 6480464 Vincristine results in decreased expression of RBL1 mRNA CTD PMID:23649840 zidovudine multiple interactions ISO RGD:1313374 6480464 [Zidovudine co-treated with Lamivudine] results in decreased expression of RBL1 mRNA CTD PMID:15784690